(Bloomberg) -- Gilead Sciences Inc. said it would acquire Ouro Medicines, a closely held company testing novel antibody drugs against autoimmune diseases, for as much as $2.18 billion. Under terms of ...
MedPage Today on MSN
Newer diabetes drugs, including GLP-1 agonists, tied to autoimmunity risk
Patterns differ among medication classes; potential mechanisms need more research ...
Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other devastating autoimmune diseases — by reprogramming patients’ out-of-whack immune ...
One potential use of GLP-1s catching scientists’ eye is the management of autoimmune disease, a general term for a health ...
A Johnson & Johnson autoimmune disease medicine that’s a relative latecomer in its drug class can now compete in its first FDA-approved indication with a label that covers a broader patient population ...
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of autoimmune rheumatic diseases, such as rheumatoid arthritis and lupus, ...
Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other devastating autoimmune diseases — by reprogramming patients’ out-of-whack immune ...
Read full article: Woman dead after vehicle hit her while crossing South Side road, SAPD says Hebert Kaleth Ibarra Castro (right) is no longer in U.S. Immigration and Customs Enforcement custody after ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results